Medical Countermeasures Platform

CPTx advances new treatment paradigms for a spectrum of medical challenges, with an initial focus on infectious diseases.

Through programmable DNA nanofabrication technology, CPTx builds advanced therapeutic agents, offering unprecedented options for designing solutions for unmet medical needs.

Development Pipeline

Proprietary Pipeline
  • Discovery
  • Preclinical Validation
  • Lead Optimization
  • IND-Enabling
  • Phase I
  • Phase II/III
CPT-001 Influenza

Infectious Diseases

Broad Virus Converge Candidates

Infectious Diseases

CPT-001 Influenza

Infectious Diseases

Preclinical Validation Phase

Broad Virus Converge Candidates

Infectious Diseases

Discovery Phase

Partnership Pipeline
In Development
In Development
image of cptx icosahedron logo

The antiviral therapeutics program at CPTx fills a vital gap for effective treatments, catering to vulnerable populations and bolstering pandemic response capabilities.

A New breakthrough

The viral countermeasures platform - universal and adaptable virus cell entry inhibitor

an infographics of cptx virusinfographics of viral countermeasures platform mobile

Viral Countermeasures Platform

  • icon of modularity four boxes

    Capture different types of viruses, regardless of form and size.

  • icon of a puzzle

    Compatibility with a wide range of virus-binding molecules such as antibodies, peptides, and polymers.

  • icon of a icosahedron

    Robust trapping of viruses, offering resistance against viral mutations.

  • icon of a layer
    Broad-Spectrum Activity

    Disable many viruses using the same formulation.

  • icon of chart decline
    Viral Load Reduction

    Suppresses the viral reproduction as a cell entry inhibitor.

  • icon of a syringe

    Intravenous, subcutaneous or intranasal administration for prevention or treatment of acute infections.

  • icon of a virus

    Built from biological material, does not interfere with host metabolism.

  • icon of a gear
    Additional Functionalities

    The system can carry additional effector functionalities to further support pathogen removal.